Cancer needs assessment in primary care

Not Applicable

Completed

• Conditions: Specialty: Primary Care, Primary sub-specialty: Cancer; UKCRC code/ Disease: Cancer/ Malignant neoplasms of independent (primary) multiple sites; Cancer; Cancer/ Malignant neoplasms of independent (primary) multiple sites

• Registration Number: ISRCTN22325477
• Lead Sponsor: niversity of Hull

Brief Summary

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33507949/ (added 29/03/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-07-05
• Study Completion: 2018-11-30
• Last Update Posted: 18 September 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Patient level:
1. Adults (aged 18 and above)
2. Diagnosis of active incurable cancer
3. Willing to have a consultation with a practice clinician
4. Able to complete study measures
5. Written or observed verbal informed consent

Carers:
1. Adults (aged 18 and above)
2. Nominated by the patient
3. Able to complete study measures
4. Written or observed verbal informed consent

Exclusion Criteria

Patient level:
1. Patients in complete remission
2. Patients receiving treatment with intent to cure (patients receiving anti-cancer treatments with the intention to palliate, OR receiving supportive care only will be eligible).
3. Patients living in a care home or other institutional setting
4. Patients who do not speak English well enough to provide informed consent and complete study measures.
5. Known to have a co-morbid condition which means they lack sufficient mental capacity to provide informed consent in the opinion of the clinician (e.g. dementia)
6. Have known of their diagnosis for less than one month

Carer level:
1. Carers who do not speak English well enough to provide informed consent and complete study measures.
2. Paid carers

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Recruitment is assessed by calculating the number of GP practices recruited, number of patients screened, eligible, contacted by usual care team, agreeing to researcher contact, and registered per practice, rate of patients (and caregivers) recruited across the feasibility sites over six months<br>2. Uptake and delivery is assessed by calculating the uptake of the NAT:PD-C, the expected number of completed NAT:PD-C forms completed per patient vs actual will be assessed, total patients by trial arm seen by a NAT:PD-C trained clinician and had a NAT:PD-C completed for that consultation, time from baseline to needs assessment appointment, length of appointments at six months<br>3. Data collection and quality: Participant reported questionnaire completion rates, amount/pattern of missing data and sub-scales of the proposed primary outcome measure the SCNS, patient/carer outcomes i.e. unmet needs, ability to care, quality of life, performance at six months